Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center is a clinical research site located in Denver, Colorado, United States 80218.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center has participated in 5 clinical trials with 2 currently active.
Therapeutic areas: Multiple Myeloma, Lymphocytic Leukemia, Chronic, Follicular Lymphoma.
Sponsors: Genentech, Inc., Hoffmann-La Roche.
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center has 5 clinical trials on record, with 2 currently active. Their work covers Multiple Myeloma, Lymphocytic Leukemia, Chronic, Follicular Lymphoma.
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.